NC
REPL icon

NewSquare Capital’s Replimune Group REPL Stock Holding History

NewSquare Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20
Closed -$464 – 831
2023
Q2 		$464 Hold
20
– – ﹤0.01% 690
2023
Q1 		$353 Hold
20
– – ﹤0.01% 742
2022
Q4 		$544 Buy
+20
New +$416 ﹤0.01% 643

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NewSquare Capital's REPL Position: Q3 2023 in Review

NewSquare Capital sold out of Replimune Group (REPL) in Q3 2023, closing a stake of 20 shares — an estimated $464 sold.

NewSquare Capital first reported a position in REPL in Q4 2022 and held it in 3 quarters. The position peaked at $544 in Q4 2022. 127 funds tracked by Wall St. Rank hold REPL as of Q3 2023.

  • NewSquare Capital reported no remaining Replimune Group position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 20 Replimune Group shares in Q3 2023, an estimated $464.
  • NewSquare Capital first reported a position in Replimune Group in Q4 2022 and held it in 3 quarters.
  • NewSquare Capital's Replimune Group position peaked at $544 in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Replimune Group as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.